Wendelboe AM, Raskob GE. Global burden of Thrombosis: epidemiologic aspects. Circ Res. 2016;118(9):1340–7.

Article  CAS  PubMed  Google Scholar 

Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, et al. Venous thromboembolism (VTE) in Europe - the number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98(4):756–64.

CAS  PubMed  Google Scholar 

Barco S, Woersching AL, Spyropoulos AC, Piovella F, Mahan CE. European Union-28: an annualised cost-of-illness model for venous thromboembolism. Thromb Haemost. 2016;115(4):800–8.

Article  PubMed  Google Scholar 

Jha AK, Larizgoitia I, Audera-Lopez C, Prasopa-Plaizier N, Waters H, Bates DW. The global burden of unsafe medical care: analytic modelling of observational studies. BMJ Quality & Safety. 2013 Oct 1;22(10):809.

Heit JA, Melton LJ, Lohse CM, Petterson TM, Silverstein MD, Mohr DN et al. Incidence of Venous Thromboembolism in Hospitalized Patients vs Community Residents. Mayo Clin Proc. 2001;76(11):1102–10.

Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ. Risk factors for deep vein Thrombosis and Pulmonary Embolism: a population-based case-control study. Arch Intern Med. 2000;160(6):809–15.

Article  CAS  PubMed  Google Scholar 

Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med. 2007;146(4):278–88.

Article  PubMed  Google Scholar 

Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 SUPPL):381S–453S.

Article  CAS  PubMed  Google Scholar 

Northup A, Wilcox S. Thromboprophylaxis failure in the Adult Medical Inpatient. Am J Med Sci. 2017;354(2):107–16.

Article  PubMed  Google Scholar 

Shepherd MF, Rosborough TK, Schwartz ML. Heparin thromboprophylaxis in gastric bypass Surgery. Obes Surg. 2003;13(2):249–53.

Article  PubMed  Google Scholar 

Ikesaka R, Delluc A, Le Gal G, Carrier M. Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric Surgery: a systematic review and meta-analysis. Thromb Res. 2014;133(4):682–7.

Article  CAS  PubMed  Google Scholar 

Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019;3(23):3898–944.

Article  PubMed  PubMed Central  Google Scholar 

Schünemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018;2(22):3198–225.

Article  PubMed  PubMed Central  Google Scholar 

Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction score. J Thromb Haemost. 2010;8(11):2450–7.

Article  CAS  PubMed  Google Scholar 

Wilson S, Chen X, Cronin MA, Dengler N, Enker P, Krauss ES, et al. Thrombosis prophylaxis in surgical patients using the Caprini risk score. Curr Probl Surg. 2022;59(11):101221.

Article  PubMed  Google Scholar 

Harrell FE, Lee KL, Mark DB. Tutorial in bioestadistics multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–87.

Article  PubMed  Google Scholar 

Stata Technical Support. Citing Stata software, documentation, and FAQs [Internet]. College Station, TX: StataCorp LLC.; 2019 [cited 2023 Jun 16]. Available from: https://www.stata.com/support/faqs/resources/citing-software-documentation-faqs/.

Blokhin IO, Lentz SR. Mechanisms of Thrombosis in obesity. Curr Opin Hematol. 2013;20(5):437.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hotoleanu C. Association between obesity and venous thromboembolism. Med Pharm Rep. 2020;93(2):162.

PubMed  PubMed Central  Google Scholar 

Joy M, Tharp E, Hartman H, Schepcoff S, Cortes J, Sieg A, et al. Safety and Efficacy of High-Dose Unfractionated Heparin for Prevention of venous thromboembolism in overweight and obese patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2016;36(7):740–8.

Article  CAS  Google Scholar 

Liu J, Qiao X, Wu M, Wang H, Luo H, Zhang H, et al. Strategies involving low-molecular-weight heparin for the treatment and prevention of venous thromboembolism in patients with obesity: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023;14:1084511.

Article  PubMed  Google Scholar 

Egan G, Ensom MHH. Measuring anti–factor xa activity to monitor low-molecular-weight heparin in obesity: a critical review. Can J Hosp Pharm. 2015;68(1):33.

PubMed  PubMed Central  Google Scholar 

Khorana AA, Mackman N, Falanga A, Pabinger I, Noble S, Ageno W, et al. Cancer-associated venous thromboembolism. Nat Reviews Disease Primers 2022. 2022;8(1):1.

Google Scholar 

Khorana AA, Connolly GC. Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol. 2009;27(29):4839–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021;5(4):927–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zwicker JI, Roopkumar J, Puligandla M, Schlechter BL, Sharda AV, Peereboom D, et al. Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial. Blood Adv. 2020;4(10):2254–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mank V, Azhar W, Brown K, Leukocytosis. StatPearls. 2023.

Yeh YT, Tsai SE, Chen YC, Yang SF, Yeh HW, Wang BY et al. Deep venous Thrombosis and risk of consequent Sepsis event: a Retrospective Nationwide Population-based Cohort Study. Int J Environ Res Public Health. 2021;18(15).

Kaplan D, Charles Casper T, Gregory Elliott C, Men S, Pendleton RC, Kraiss LW, et al. VTE incidence and risk factors in patients with severe Sepsis and septic shock. Chest. 2015;148(5):1224–30.

Article  PubMed  PubMed Central  Google Scholar 

Lim W, Meade M, Lauzier F, Zarychanski R, Mehta S, Lamontagne F, et al. Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically Ill patients. Crit Care Med. 2015;43(2):401–10.

Article  CAS  PubMed  Google Scholar 

Cook D, Attia J, Weaver B, McDonald E, Meade M, Crowther M. Venous thromboembolic Disease: an observational study in medical-surgical intensive care unit patients. J Crit Care. 2000;15(4):127–32.

Article  CAS  PubMed  Google Scholar 

Hanify JM, Dupree LH, Johnson DW, Ferreira JA. Failure of chemical thromboprophylaxis in critically ill medical and surgical patients with sepsis. J Crit Care. 2017;37:206–10.

Article  PubMed  Google Scholar 

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant. Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU) - Full Text View - ClinicalTrials.gov.

Arabi Y, Al-Hameed F, Burns KEA, Mehta S, Alsolamy S, Almaani M et al. Statistical analysis plan for the pneumatic CompREssion for PreVENting venous thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial. Trials. 2018;19(1).